FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1779-1783 December 5, 1996 Number 23

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

The Marlboro Man and Joe Camel have become public health enemies number one and two, and removing their familiar faces from the gaze of young people has become a goal of President Bill Clinton and his health care officials.¹ The strategy of limiting the exposure of children to tobacco advertisements is based on the fact that almost all regular smokers begin smoking in their teens. This approach is politically possible because most Americans believe that tobacco companies should be prohibited from targeting children in their advertising.

Shortly before the 1996 Democratic National Convention, the President announced that he had approved . . . [Full Text of this Article]

The Regulations

The Legal Challenge

The First Amendment and Advertising

The 44 Liquormart Case

Free Speech and the FDA Regulations

References

This article has been cited by other articles:

• Glantz, L. H., Annas, G. J. (2000). Tobacco, the Food and Drug Administration, and Congress. NEJM 343: 1802-1806 [Full Text]  
• Strasburger, V. C., Donnerstein, E. (1999). Children, Adolescents, and the Media: Issues and Solutions. Pediatrics 103: 129-139 [Full Text]  
• Annas, G. J. (1997). Tobacco Litigation as Cancer Prevention: Dealing with the Devil. NEJM 336: 304-309 [Full Text]